I'll give some credit to oc as well as things are going quite well for VRUS. Still a ways to go in the clinic though. And you just have to wonder how much more upside there is from $4.5B market cap even if things do go according to plan. What is the best-case scenario if the two 2nd gen nukes become cogs in the HCV space? Just thinking about a fair number for peak sales potential for these nukes and what a fair multiple is on sales to arrive at a market cap for VRUS. Does anyone care to toss out any wild numbers as I honestly haven't seen any and I'm just curious about where VRUS could go in a best-case scenario?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.